VSee Health, Inc. (VSEE)
Automate Your Wheel Strategy on VSEE
With Tiblio's Option Bot, you can configure your own wheel strategy including VSEE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VSEE
- Rev/Share 1.2375
- Book/Share 0.8975
- PB 0.9248
- Debt/Equity 2.1689
- CurrentRatio 0.3701
- ROIC -3.6502
- MktCap 13001766.0
- FreeCF/Share -0.3696
- PFCF -6.6339
- PE -0.083
- Debt/Assets 0.4124
- DivYield 0
- ROE -3.3422
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | VSEE | Maxim Group | -- | Buy | -- | $5 | Feb. 24, 2025 |
News
VSee Health Appeals NASDAQ Staff Delisting Notice
Published: August 12, 2025 by: Accesswire
Sentiment: Neutral
SAN JOSE, CA / ACCESS Newswire / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market. VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing requirements because it had not filed its Annual Report on Form 10-K for period ending December 31, 2024, and its Quarterly …
Read More
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial
Published: June 23, 2025 by: Business Wire
Sentiment: Neutral
SAN JOSE, Calif.--(BUSINESS WIRE)-- #clinicaltrial--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke surviv.
Read More
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines
Published: May 16, 2025 by: Business Wire
Sentiment: Neutral
SAN JOSE, Calif.--(BUSINESS WIRE)-- #AIinHealthcare--VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboa.
Read More
About VSee Health, Inc. (VSEE)
- IPO Date 2021-12-31
- Website https://www.vseehealth.com
- Industry Medical - Healthcare Information Services
- CEO Imoigele P. Aisiku
- Employees 2